Form 4: Cytokinetics Director Robert Harrington Sells 900 Shares
SEC Form 4 Filing
Director Robert Harrington sold 900 shares of Cytokinetics Inc. (CYTK) at $42.5 per share on March 4, 2025.
Summary
- On March 4, 2025, Robert Arthur Harrington, a director of Cytokinetics Inc. (CYTK), sold 900 shares of common stock.
- The sale price was $42.5 per share.
- Following the transaction, Harrington directly owns 15,108 shares of Cytokinetics Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by an insider. It doesn't inherently convey positive or negative sentiment, but the sale of shares could be interpreted neutrally or slightly negatively depending on the context.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of transaction: Robert Harrington sold 900 shares of CYTK at $42.5 per share. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.